Want to join the conversation?
$AVGO 3Q15 Q&A: Arya from BofA asked how we should think about OpEx trajectory over the next few quarters. Tony answered OpEx going forward, $335MM and then steady decline with Emulex getting further along the way on their cost cutting, I think is the way we look at it. So we are crewing above 100% and you will see that tail off in 1Q16.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?